PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome
Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer’s disease except for the putamen
Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer’s disease in Down syndrome
Leisure activity in middle-aged adults with Down syndrome: Initiators, social partners, settings and barriers
Physiological arousal and observed behavior in parent-child interactions involving young children with Down syndrome
